The management of colorectal cancer is undergoing rapid transformation, driven by advances in surgical technology, precision oncology, and multidisciplinary care. Robotic platforms are redefining what is technically achievable, enabling greater precision and potentially improved functional outcomes. At the same time, organ-preserving strategies are challenging traditional operative paradigms, offering carefully selected patients the possibility of avoiding radical surgery without compromising oncologic safety. Parallel to these developments, immunotherapy is reshaping the treatment landscape for mismatch repair deficient cancers, with emerging evidence of durable and, in some cases, practice-changing responses. This session brings together experts across surgery and oncology to explore how these innovations intersect. From advanced robotic rectal surgery to non-operative management and immunotherapy-driven treatment pathways, the discussion will focus on how to integrate evolving evidence into contemporary colorectal practice. The session will provide insight into the opportunities—and challenges—of delivering personalised, outcomes-focused care in an era of rapidly advancing technology and therapeutics.